Gosselies, Belgium – Évry, France July 9th, 2020
This transaction would bring together OncoDNA’s expertise in oncology precision medicine and IntegraGen’s know-how in DNA sequencing services and bioinformatics analyses. The combination of both companies would enable to offer a complete solution that combines oncology laboratory testing and software solutions which will benefit the treatment of patients with advanced cancer.
OncoKDM® used as the support SaaS platform in a prospective pilot study of Veneto Institute of Oncology – IRCCS
Gosselies, 1st September 2020 – ONCODNA (“OncoDNA or “the Company”), the healthcare technology company making precision medicine in oncology a reality, is pleased to announce that its OncoKDM® platform was used to support a pilot...